Oxford vaccine offers hope, Serum to seek clinical trials in India

The first set of results from early-stage clinical trials of the Oxford University Covid-19 vaccine candidate show the vaccine is safe and induces an immune reaction, according to results published in the Lancet, a medical journal, on Monday. The results from Oxford were followed by Indian vaccine manufacturer Serum Institute announcing it would seek regulatory approvals for clinical trials in India.

from UK News Headlines, Latest UK News and Live Updates - Times of India https://ift.tt/3eJ8bep